PT-141
Melanocortin receptor agonist peptide studied for sexual function and CNS arousal pathway research. 10mg lyophilized powder.
Description
Research Overview
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. Unlike PDE5 inhibitors, research has shown it acts centrally through MC3R and MC4R receptors in the hypothalamus, making it a tool for studying CNS-mediated arousal pathways. Note: while bremelanotide is an FDA-approved drug (Vyleesi), these research-grade vials are not FDA-approved drug products.
Specifications
- Quantity: 10mg per vial
- Form: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Storage: -20°C, protect from light
For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.
All products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. By purchasing, you agree to our research policy and confirm you are a qualified researcher.
